Toth Financial Advisory Corp Ascendis Pharma A/S Transaction History
Toth Financial Advisory Corp
- $823 Million
- Q2 2025
A detailed history of Toth Financial Advisory Corp transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Toth Financial Advisory Corp holds 445 shares of ASND stock, worth $74,524. This represents 0.01% of its overall portfolio holdings.
Number of Shares
445
Previous 5,335
91.66%
Holding current value
$74,524
Previous $831,000
90.85%
% of portfolio
0.01%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding ASND
# of Institutions
272Shares Held
61.7MCall Options Held
151KPut Options Held
226K-
Ra Capital Management, L.P. Boston, MA10.3MShares$1.72 Billion33.28% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$918 Million4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.22MShares$874 Million13.16% of portfolio
-
Janus Henderson Group PLC London, X04.49MShares$751 Million0.4% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$713 Million1.14% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $9.35B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...